Taizong Biotechnology

Taizong Biotechnology is a specialized life sciences company headquartered in Shanghai, China, focusing on the advancement of exosome technology. The company has developed a proprietary platform for the high-purity isolation and comprehensive analysis of exosomes, which are critical for intercellular communication and biomarker discovery. Taizong offers a range of research products, including exosome isolation kits and characterization services, while simultaneously advancing a pipeline of exosome-based liquid biopsy diagnostics for early cancer detection. Their work spans multiple therapeutic areas, including oncology and cardiovascular health, aiming to translate exosome research into clinical diagnostic and therapeutic solutions. The company serves a broad client base of academic institutions, hospitals, and pharmaceutical companies seeking to leverage exosomes for precision medicine.